Facebook
Twitter
LinkedIn
ForwardAntineoplastic Therapy and Immunotherapy Course Summer 2022
This four-day course is designed to address the needs of the nursing and other oncology professionals in relation to chemotherapy and biological therapies. It includes information on current and investigational pharmacotherapy, safe handling, administration of antineoplastic agents, and various issues concerning the management of patients receiving cancer therapy.
Target Audience
Healthcare providers who will care for patients' receiving chemotherapy and immunotherapy.
Learning Objectives
After participation in this activity, the learner will be able to:
• Discuss the expectations related to class content and the participant’s professional responsibilities
• Discuss the roles of chemotherapy and biotherapy in the treatment of cancer
• Recall the pharmacology of different classes of antineoplastic and supportive therapies
• Recognize side effects and organ toxicities that patients may experience while receiving antineoplastic and supportive therapies
• Discuss management strategies for patients receiving antineoplastic and/or supportive therapies, including the prevention and treatment of toxicities and side effects
• Describe the safe administration of antineoplastic and supportive therapies
• Identify interventions to prevent chemotherapy errors
• Develop a patient care management plan for a patient receiving antineoplastic therapies and supportive therapies
• Identify three resources for oncology healthcare providers to utilize
Antineoplastic Therapy and Immunotherapy Course
This four-day course is designed to address the needs of the nursing and other oncology professionals in relation to chemotherapy and biological therapies. It includes information on current and investigational pharmacotherapy, safe handling, administration of antineoplastic agents, and various issues concerning the management of patients receiving cancer therapy.
This course is NOT a certification course and is not intended to measure competency. Individual institutions are responsible for determining their own requirements for assessing clinical competency.
To ensure room capacity adherence with COVID restrictions live class attendance is reserved for UPMC Shadyside Campus Employees all other staff will attend Remotely via MS Teams. Please reach out to the course director for questions or concerns.
Day 1 - August 15, 2022 Herberman 201AB
Day 2 - August 18, 2022 Cooper A
Day 3 - August 25, 2022 Herberman 201AB
Day 4 - August 28, 2022 Cooper A
Amanda Agnew, PharmD, BCPS, BCOP | Melissa Bastacky, PharmD, BCOP | Melissa K. Bourdius, MS, CGC
|
Tom G. Boyer, PA-C | Tim Brenner, PharmD, BCOP | Amy DiMaggio, MSN, RN, CMSRN, OCN |
Shrina Duggal, PharmD, BCOP | Timothy George, PharmD, BCOP | Paul Huffman, PharmD |
Nicole Kahler, DNP, CRNP, AOCNP | Jaime Kriner, PA-C | Diana Mansour, PharmD |
Brian Miller, PharmD | Katey Murgi, MSN, RN | Lynne O’Connor, MSN, RN |
Alyssa Owens, MPAS, PA-C | Brittni Prosdocimo, MSN, RN, BMTCN | Trish Seaman, MSN, RN, CMSRN |
Jason Steele, PharmD, BCOP | Courtney Stetor, MPAS PA-C |
|
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Pittsburgh has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria.
This activity is designated for 25.25 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
The maximum number of hours awarded for this Continuing Nursing Education activity is 25.25 contact hours.
To receive 25.25 Contact Hours, the learner must sign in, attend the entire activity, pass course test with a score of 80% or greater and complete the activity evaluation.
Available Credit
- 25.25 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 25.25 APA
- 25.25 Attendance